The evolution of research and development in the pharmaceutical industry: toward the open innovation model – can pharma reinvent itself?

International Journal of Business Innovation and Research(2010)

引用 14|浏览7
暂无评分
摘要
The global pharmaceutical industry is facing diminishing returns from its massive investment in research and development. This is particularly troublesome because the industry has long enjoyed monopoly rents that come from innovative new drugs. The purpose of this paper is to examine the extant R&D practices in the industry and make a strong case for a shift to the open innovation model. Potential roadblocks to adopting the open innovation model are identified as well as ways to overcome these roadblocks. This conceptual paper makes use of archival R&D and sales data to support its contentions.
更多
查看译文
关键词
open innovation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要